Perfusion estimated with rapid dynamic contrast-enhanced magnetic resonance imaging correlates inversely with vascular endothelial growth factor expression and pimonidazole staining in head-and-neck cancer: a pilot study.
暂无分享,去创建一个
D. Buckley | L. Kershaw | C. West | G. Betts | J. Homer | N. Slevin | H. Valentine | S. Donaldson | S. Bonington
[1] L. Bains,et al. Tracer kinetic analysis of dynamic contrast‐enhanced MRI and CT bladder cancer data: A preliminary comparison to assess the magnitude of water exchange effects , 2010, Magnetic resonance in medicine.
[2] Jason A Koutcher,et al. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. , 2010, International journal of radiation oncology, biology, physics.
[3] S. Sourbron,et al. A comparison of tracer kinetic models for T1‐weighted dynamic contrast‐enhanced MRI: Application in carcinoma of the cervix , 2010, Magnetic resonance in medicine.
[4] A. Padhani,et al. Science to practice: what does MR oxygenation imaging tell us about human breast cancer hypoxia? , 2010, Radiology.
[5] L. D. McPhail,et al. Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis. , 2010, Radiology.
[6] Kevin Harrington,et al. An exploratory study into the role of dynamic contrast-enhanced magnetic resonance imaging or perfusion computed tomography for detection of intratumoral hypoxia in head-and-neck cancer. , 2009, International journal of radiation oncology, biology, physics.
[7] Z. Rumboldt,et al. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume. , 2009, International journal of radiation oncology, biology, physics.
[8] C. Hutchinson,et al. Benign prostatic hyperplasia: Evaluation of T1, T2, and microvascular characteristics with T1‐weighted dynamic contrast‐enhanced MRI , 2009, Journal of magnetic resonance imaging : JMRI.
[9] Alan Jackson,et al. Comparison of normal tissue R1 and R *2 modulation by oxygen and carbogen , 2009, Magnetic resonance in medicine.
[10] Michael F. Milosevic,et al. Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: A pilot study in men with prostate cancer , 2009, International journal of radiation biology.
[11] Avraham Eisbruch,et al. Early prediction of outcome in advanced head-and-neck cancer based on tumor blood volume alterations during therapy: a prospective study. , 2008, International journal of radiation oncology, biology, physics.
[12] Marko Seppänen,et al. 18F-EF5: A New PET Tracer for Imaging Hypoxia in Head and Neck Cancer , 2008, Journal of Nuclear Medicine.
[13] M. Haris,et al. Dynamic contrast‐enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 (MMP‐9) expression in brain tuberculomas , 2008, Journal of magnetic resonance imaging : JMRI.
[14] T. Vogl,et al. A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract , 2008, European Radiology.
[15] C. Thng,et al. Dynamic contrast-enhanced CT of head and neck tumors: perfusion measurements using a distributed-parameter tracer kinetic model. Initial results and comparison with deconvolution-based analysis , 2007, Physics in medicine and biology.
[16] David J Collins,et al. Hypoxia in prostate cancer: correlation of BOLD-MRI with pimonidazole immunohistochemistry-initial observations. , 2007, International journal of radiation oncology, biology, physics.
[17] Crispin J. Miller,et al. Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers. , 2007, Cancer research.
[18] S. Mukherji,et al. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? , 2007, AJNR. American journal of neuroradiology.
[19] Sotirios Bisdas,et al. Dynamic contrast-enhanced CT of head and neck tumors: Perfusion measurements using a distributed-parameter tracer kinetic model , 2006 .
[20] D. Buckley,et al. Precision in measurements of perfusion and microvascular permeability with T1‐weighted dynamic contrast‐enhanced MRI , 2006, Magnetic resonance in medicine.
[21] D. Brizel,et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[22] Frédérique Frouin,et al. Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma , 2005, European Radiology.
[23] Anthony Fyles,et al. Assessment of the tumor microenvironment in cervix cancer using dynamic contrast enhanced CT, interstitial fluid pressure and oxygen measurements. , 2005, International journal of radiation oncology, biology, physics.
[24] R. Lucht,et al. Microcirculation and microvasculature in breast tumors: Pharmacokinetic analysis of dynamic MR image series , 2004, Magnetic resonance in medicine.
[25] Tove Grönroos,et al. Imaging perfusion and hypoxia with PET to predict radiotherapy response in head-and-neck cancer. , 2004, International Journal of Radiation Oncology, Biology, Physics.
[26] Philippe Lambin,et al. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. , 2003, International journal of radiation oncology, biology, physics.
[27] Orhan Nalcioglu,et al. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer , 2003, Journal of magnetic resonance imaging : JMRI.
[28] Johan Bussink,et al. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. , 2002, Cancer research.
[29] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[30] J. Overgaard,et al. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. , 2001, International journal of radiation oncology, biology, physics.
[31] M. Varia,et al. Semiquantitative immunohistochemical analysis for hypoxia in human tumors. , 2001, International journal of radiation oncology, biology, physics.
[32] P. Carmeliet,et al. Angiogenesis in cancer and other diseases , 2000, Nature.
[33] J. Logue,et al. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix , 2000, British Journal of Cancer.
[34] H. Lyng,et al. Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis , 2000, British Journal of Cancer.
[35] M. Knopp,et al. Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.
[36] M C Weissler,et al. Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker. , 1998, Cancer research.
[37] L. Bastholt,et al. A randomized double-blind phase III study of nimorazole as a hypoxic radiosensitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Danish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[38] P. Okunieff,et al. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. , 1989, Cancer research.
[39] D Matthaei,et al. Dynamic digital subtraction imaging using fast low-angle shot MR movie sequence. , 1986, Radiology.